Manisha Narasimhan

Chief Corporate Development and Digital Officer, Bausch + Lomb

Dr. Manisha Narasimhan is a co-founder and Chief Financial Officer of Vesper Healthcare Acquisition Corp. Dr. Narasimhan has over fifteen years of experience working with leading pharmaceutical and biotechnology companies. Dr. Narasimhan joined Allergan in December 2018 and most recently served as Senior Vice President of Strategic Initiatives, Portfolio Innovation and Investor Relations from August 2019 to May 2020. Prior to joining Allergan, Dr. Narasimhan worked at Regeneron Pharmaceuticals where she led the investor relations group. Prior to joining Regeneron, Dr. Narasimhan was an equity research analyst covering biotechnology at Canaccord Genuity and at Piper Jaffray . Dr. Narasimhan began her career as a strategy consultant for pharmaceutical and biotechnology companies at Campbell Alliance Group Inc. Dr. Narasimhan received her Ph.D in molecular biology from New York University. Additionally, Dr. Narasimhan serves on the Board of Cytonus Therapeutics, a private biotechnology company.